Literature DB >> 15916734

Distribution of cysteinyl leukotriene receptor 2 in human traumatic brain injury and brain tumors.

Hua Hu1, Gao Chen, Jian-min Zhang, Wei-ping Zhang, Lei Zhang, Qiu-fu Ge, Hong-tian Yao, Wei Ding, Zhong Chen, Er-qing Wei.   

Abstract

AIM: To determine the distribution of cysteinyl leukotriene receptor 2 (CysLT2), one of the cysteinyl leukotriene receptors, in human brains with traumatic injury and tumors.
METHODS: Brain specimens were obtained from patients who underwent brain surgery. CysLT2 in brain tissues was examined using immunohistochemical analysis.
RESULTS: CysLT2 was expressed in the smooth muscle cells (not in the endothelial cells) of arteries and veins. CysLT2 was also expressed in the granulocytes in both vessels and in the brain parenchyma. In addition, CysLT2 was detected in neuron- and glial-appearing cells in either the late stages of traumatic injury or in the area surrounding the tumors. Microvessels regenerated 8 d after trauma and CysLT2 expression was recorded in their endothelial cells.
CONCLUSION: CysLT2 is distributed in vascular smooth muscle cells and granulocytes, and brain trauma and tumor can induce its expression in vascular endothelial cells and in a number of other cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15916734     DOI: 10.1111/j.1745-7254.2005.00092.x

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  7 in total

1.  Blocking leukotriene synthesis attenuates the pathophysiology of traumatic brain injury and associated cognitive deficits.

Authors:  Chelsea E Corser-Jensen; Dayton J Goodell; Ronald K Freund; Predrag Serbedzija; Robert C Murphy; Santiago E Farias; Mark L Dell'Acqua; Lauren C Frey; Natalie Serkova; Kim A Heidenreich
Journal:  Exp Neurol       Date:  2014-03-25       Impact factor: 5.330

2.  Injury-related production of cysteinyl leukotrienes contributes to brain damage following experimental traumatic brain injury.

Authors:  Santiago Farias; Lauren C Frey; Robert C Murphy; Kim A Heidenreich
Journal:  J Neurotrauma       Date:  2009-11       Impact factor: 5.269

3.  A Dual Role for Cysteinyl Leukotriene Receptors in the Pathogenesis of Corneal Infection.

Authors:  Thomas W Carion; Yuxin Wang; Ashten Stambersky; Abdul Shukkur Ebrahim; Elizabeth A Berger
Journal:  J Immunol       Date:  2022-04-25       Impact factor: 5.426

4.  Endothelial cysteinyl leukotriene 2 receptor expression mediates myocardial ischemia-reperfusion injury.

Authors:  Wei Jiang; Sean R Hall; Michael P W Moos; Richard Yang Cao; Satoshi Ishii; Kofo O Ogunyankin; Luis G Melo; Colin D Funk
Journal:  Am J Pathol       Date:  2008-02-14       Impact factor: 4.307

Review 5.  Interactions between prostaglandins, leukotrienes and HIV-1: possible implications for the central nervous system.

Authors:  Jonathan Bertin; Corinne Barat; Sylvie Méthot; Michel J Tremblay
Journal:  Retrovirology       Date:  2012-01-11       Impact factor: 4.602

6.  Leukotrienes inhibit early stages of HIV-1 infection in monocyte-derived microglia-like cells.

Authors:  Jonathan Bertin; Corinne Barat; Dave Bélanger; Michel J Tremblay
Journal:  J Neuroinflammation       Date:  2012-03-16       Impact factor: 8.322

Review 7.  Cysteinyl Leukotrienes as Potential Pharmacological Targets for Cerebral Diseases.

Authors:  Paolo Gelosa; Francesca Colazzo; Elena Tremoli; Luigi Sironi; Laura Castiglioni
Journal:  Mediators Inflamm       Date:  2017-05-10       Impact factor: 4.711

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.